ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 716 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,321 | +12.1% | 5,911 | +18.5% | 0.03% | +20.0% |
| Q2 2023 | $357,144 | +0.9% | 4,990 | -2.2% | 0.02% | 0.0% |
| Q1 2023 | $353,999 | -45.8% | 5,100 | -47.1% | 0.02% | -50.0% |
| Q4 2022 | $653,559 | +139.4% | 9,639 | +93.4% | 0.05% | +117.4% |
| Q3 2022 | $273,000 | +4.6% | 4,983 | +26.3% | 0.02% | +9.5% |
| Q2 2022 | $261,000 | -10.3% | 3,945 | -10.0% | 0.02% | +5.0% |
| Q1 2022 | $291,000 | +13.7% | 4,384 | -0.3% | 0.02% | +17.6% |
| Q4 2021 | $256,000 | +7.6% | 4,397 | +10.8% | 0.02% | 0.0% |
| Q3 2021 | $238,000 | +3.5% | 3,969 | +3.4% | 0.02% | -5.6% |
| Q2 2021 | $230,000 | -5.7% | 3,837 | -21.3% | 0.02% | -28.0% |
| Q4 2020 | $244,000 | -82.5% | 4,873 | -80.8% | 0.02% | -76.6% |
| Q3 2020 | $1,391,000 | +465.4% | 25,381 | +414.0% | 0.11% | +245.2% |
| Q4 2019 | $246,000 | – | 4,938 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |